ZIFF DAVIS, INC.
For the period ended Mar 31, 2026. Filed May 8, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2026 · Filed May 8, 2026
ZD$51.14+1.1%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Cash Flows (Unaudited)
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited, in thousands)
| Three months ended March 31, | ||
|---|---|---|
| 2026 | 2025 | |
| Cash flows from operating activities: | ||
| Net income | $22,261 | $24,239 |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||
| Depreciation and amortization | 49,783 | 55,832 |
| Non-cash operating lease costs | 2,037 | 2,034 |
| Share-based compensation | 10,913 | 9,752 |
| Provision for credit losses on accounts receivable | 1,129 | 160 |
| Deferred income taxes, net | (12,323) | 548 |
| Changes in fair value of contingent consideration | 124 | (1,803) |
| Income from equity method investments, net of tax | (5,138) | (6,630) |
| Other | 1,129 | 912 |
| Decrease (increase) in: | ||
| Accounts receivable | 195,297 | 143,721 |
| Prepaid expenses and other current assets | (3,826) | (17,709) |
| Other assets | (1,813) | 7,252 |
| Increase (decrease) in: | ||
| Accounts payable | (247,695) | (210,857) |
| Deferred revenue | 22,894 | 18,493 |
| Accrued liabilities and other current liabilities | (4,819) | (5,331) |
| Net cash provided by operating activities | 29,953 | 20,613 |
| Cash flows from investing activities: | ||
| Purchases of property and equipment | (33,127) | (25,619) |
| Acquisitions, net of cash received | — | (39,198) |
| Other | (80) | (12) |
| Net cash used in investing activities | (33,207) | (64,829) |
| Cash flows from financing activities: | ||
| Repurchase of common stock | (51,594) | (34,900) |
| Other | (1,901) | (106) |
| Net cash used in financing activities | (53,495) | (35,006) |
| Effect of exchange rate changes on cash and cash equivalents | (4,446) | 4,349 |
| Net change in cash and cash equivalents | (61,195) | (74,873) |
| Cash and cash equivalents at beginning of period | 607,011 | 505,880 |
| Cash and cash equivalents at beginning of period associated with discontinued operations | 33,234 | 18,380 |
| Cash and cash equivalents at beginning of period associated with continuing operations | 573,777 | 487,500 |
| Cash and cash equivalents at end of period | 545,816 | 431,007 |
| Cash and cash equivalents at end of period associated with discontinued operations | 26,098 | 19,090 |
| Cash and cash equivalents at end of period associated with continuing operations | $519,718 | $411,917 |
-6-
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.